Paul Duguid

OverviewAI-generated summary

Paul Duguid's research program focuses on understanding the neuroimmune interactions involved in the onset and progression of Fetal Alcohol Spectrum Disorders (FASD), with a particular emphasis on neuroinflammation's role in cognitive deficits associated with FASD. He is a Principal Investigator on multiple federal grants from the NIH/National Institute on Alcohol Abuse and Alcoholism and the NIH/National Institute of General Medical Sciences, totaling over $1.1 million. These grants support studies investigating dynamic neuroimmune interactions and the role of neuroinflammation in FASD cognitive deficits. Duguid also leads training grants focused on Systems Pharmacology and Toxicology (T-SPaT) and Systems Pharmacology and Toxicology Training Programs.

Duguid's scholarly output includes 110 publications with over 33,000 citations and an h-index of 30, designating him as a highly cited researcher. His recent publications span diverse areas, including the characterization of particle beams, strategies for training under-represented researchers, and the distinction between translational science and translational research within clinical and translational science award (CTSA) pilot studies. He has also published on communities of practice and the composition of telehealth, indicating a broad interest in knowledge dissemination and the implementation of new healthcare practices. His collaborations include work with Beatrice A. Boateng and Brian Gittens at the University of Arkansas for Medical Sciences.

Metrics

• h-index: 30
• Publications: 110
• Citations: 33,603